Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 1504

1.

F-18 fluorodeoxyglucose positron emission tomography in the non-invasive staging of non-small cell lung cancer.

Berlangieri SU, Scott AM, Knight SR, Fitt GJ, Hennessy OF, Tochon-Danguy HJ, Clarke CP, McKay WJ.

Eur J Cardiothorac Surg. 1999 Sep;16 Suppl 1:S25-30.

PMID:
10536941
2.

Preoperative intrathoracic lymph node staging in patients with non-small-cell lung cancer: accuracy of integrated positron emission tomography and computed tomography.

Billé A, Pelosi E, Skanjeti A, Arena V, Errico L, Borasio P, Mancini M, Ardissone F.

Eur J Cardiothorac Surg. 2009 Sep;36(3):440-5. doi: 10.1016/j.ejcts.2009.04.003. Epub 2009 May 22. Review.

PMID:
19464906
3.

Test performance of positron emission tomography and computed tomography for mediastinal staging in patients with non-small-cell lung cancer: a meta-analysis.

Gould MK, Kuschner WG, Rydzak CE, Maclean CC, Demas AN, Shigemitsu H, Chan JK, Owens DK.

Ann Intern Med. 2003 Dec 2;139(11):879-92. Review.

PMID:
14644890
4.

Towards a minimally invasive staging strategy in NSCLC: analysis of PET positive mediastinal lesions by EUS-FNA.

Annema JT, Hoekstra OS, Smit EF, Veseliç M, Versteegh MI, Rabe KF.

Lung Cancer. 2004 Apr;44(1):53-60.

PMID:
15013583
5.

Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography.

Lardinois D, Weder W, Hany TF, Kamel EM, Korom S, Seifert B, von Schulthess GK, Steinert HC.

N Engl J Med. 2003 Jun 19;348(25):2500-7.

6.

Diagnosis efficacy of structural (CT) and functional (FDG-PET) imaging methods in the thoracic and extrathoracic staging of non-small cell lung cancer.

Rodríguez Fernández A, Gómez Río M, Llamas Elvira JM, Sánchez-Palencia Ramos A, Bellón Guardia M, Ramos Font C, Torné Poyatos P, Pedraza Muriel V.

Clin Transl Oncol. 2007 Jan;9(1):32-9.

PMID:
17272228
7.

FDG-PET in staging and restaging non-small cell lung cancer after neoadjuvant chemoradiotherapy: correlation with histopathology.

Ryu JS, Choi NC, Fischman AJ, Lynch TJ, Mathisen DJ.

Lung Cancer. 2002 Feb;35(2):179-87.

PMID:
11804691
8.

The impact of fluorodeoxyglucose F 18 positron-emission tomography on the surgical staging of non-small cell lung cancer.

Vesselle H, Pugsley JM, Vallières E, Wood DE.

J Thorac Cardiovasc Surg. 2002 Sep;124(3):511-9.

9.

Integrated fluorine-18 fluorodeoxyglucose (18F-FDG) PET/CT compared to standard contrast-enhanced CT for characterization and staging of pulmonary tumors eligible for surgical resection.

Quaia E, Tona G, Gelain F, Lubin E, Pizzolato R, Boscolo E, Bussoli L.

Acta Radiol. 2008 Nov;49(9):995-1004. doi: 10.1080/02841850802291259.

PMID:
18651256
10.

FDG-PET imaging for lymph node staging and pathologic tumor response after neoadjuvant treatment of non-small cell lung cancer.

Ohtsuka T, Nomori H, Ebihara A, Watanabe K, Kaji M, Naruke T, Suemasu K, Uno K.

Ann Thorac Cardiovasc Surg. 2006 Apr;12(2):89-94.

PMID:
16702929
12.

18-fluorodeoxyglucose positron emission tomography enhances computed tomography diagnosis of malignant intraductal papillary mucinous neoplasms of the pancreas.

Sperti C, Bissoli S, Pasquali C, Frison L, Liessi G, Chierichetti F, Pedrazzoli S.

Ann Surg. 2007 Dec;246(6):932-7; discussion 937-9.

PMID:
18043094
13.

Feasibility of [18F]FDG-PET and coregistered CT on clinical target volume definition of advanced non-small cell lung cancer.

Messa C, Ceresoli GL, Rizzo G, Artioli D, Cattaneo M, Castellone P, Gregorc V, Picchio M, Landoni C, Fazio F.

Q J Nucl Med Mol Imaging. 2005 Sep;49(3):259-66.

14.

[Staging of non-small cell lung cancer. Diagnosis efficacy of structural (CT) and functional (FDG-PET) imaging methods].

Rodríguez Fernández A, Bellón Guardia ME, Gómez Río M, Ramos Font C, Sánchez-Palencia Ramos A, Llamas Elvira JM, Pedraza Muriel V.

Rev Clin Esp. 2007 Dec;207(11):541-7. Spanish.

PMID:
18021641
15.

The accuracy of integrated PET-CT compared with dedicated PET alone for the staging of patients with nonsmall cell lung cancer.

Cerfolio RJ, Ojha B, Bryant AS, Raghuveer V, Mountz JM, Bartolucci AA.

Ann Thorac Surg. 2004 Sep;78(3):1017-23; discussion 1017-23.

PMID:
15337041
16.

Detection of extrathoracic metastases by positron emission tomography in lung cancer.

Weder W, Schmid RA, Bruchhaus H, Hillinger S, von Schulthess GK, Steinert HC.

Ann Thorac Surg. 1998 Sep;66(3):886-92; discussion 892-3.

PMID:
9768946
17.

Value of PET/CT versus enhanced CT for locoregional lymph nodes in non-small cell lung cancer.

Yang W, Fu Z, Yu J, Yuan S, Zhang B, Li D, Xing L, Zhao D, Mu D, Sun X, Fang Y, Huang Y, Li W.

Lung Cancer. 2008 Jul;61(1):35-43. doi: 10.1016/j.lungcan.2007.11.007. Epub 2008 Jan 4. Erratum in: Lung Cancer. 2009 Feb;63(2):305. Huange, Yong [corrected to Huang, Yong].

PMID:
18177978
18.

Comparison of bone and 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography in the evaluation of bony metastases in lung cancer.

Gayed I, Vu T, Johnson M, Macapinlac H, Podoloff D.

Mol Imaging Biol. 2003 Jan-Feb;5(1):26-31.

PMID:
14499159
19.

Scanning with 18F-FDG-PET/CT for detection of pelvic nodal involvement in inguinal node-positive penile carcinoma.

Graafland NM, Leijte JA, Valdés Olmos RA, Hoefnagel CA, Teertstra HJ, Horenblas S.

Eur Urol. 2009 Aug;56(2):339-45. doi: 10.1016/j.eururo.2009.05.016. Epub 2009 May 19.

PMID:
19477581
20.

Regional nodal staging with 18F-FDG PET-CT in non-small cell lung cancer: Additional diagnostic value of CT attenuation and dual-time-point imaging.

Li M, Wu N, Liu Y, Zheng R, Liang Y, Zhang W, Zhao P.

Eur J Radiol. 2012 Aug;81(8):1886-90. doi: 10.1016/j.ejrad.2011.03.074. Epub 2011 Apr 20.

PMID:
21511421

Supplemental Content

Support Center